Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 3 November 2017 |
| Author/s |
author: emmanuel ndashimye Ann Sarah Walker Jennifer A Thompson Cissy Kityo Margaret Thomason Anne Hoppe Joep J van Oosterhout Philippa Easterbrook Andrew Kambugu Abraham Siika Raymond Mwebaze Nicholas Iain Paton Aggrey Mweemba Peter Mugyenyi George Abongomera Abbas Lugemwa Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team |
| Publication date | November 3, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |